Similar articles

• Immunosuppressives in uveitis. A preliminary report of experience with chlorambucil.

  Dinning WJ, Perkins ES. Dinning WJ, et al. Br J Ophthalmol. 1975 Aug;59(8):397-403. doi: 10.1136/bjo.59.8.397. Br J Ophthalmol. 1975. PMID: 1081881 Free PMC article. No abstract available.
• Chlorambucil dosage in frequently relapsing nephrotic syndrome: a controlled clinical trial.

  Baluarte HJ, Hiner L, Gruskin AB. Baluarte HJ, et al. J Pediatr. 1978 Feb;92(2):295-8. doi: 10.1016/s0022-3476(78)80030-4. J Pediatr. 1978. PMID: 621612 Clinical Trial.
• Correction: Cancer Chemotherapy Protocols and dose of chlorambucil.

  Ignoffo RJ, Forni P. Ignoffo RJ, et al. Ann Intern Med. 1989 Sep 15;111(6):543. doi: 10.7326/0003-4819-111-6-543_1. Ann Intern Med. 1989. PMID: 2774383 No abstract available.
• Steroids.

  Frangie JP, Leibowitz HM. Frangie JP, et al. Int Ophthalmol Clin. 1993 Fall;33(4):9-29. doi: 10.1097/00004397-199303340-00004. Int Ophthalmol Clin. 1993. PMID: 8258501 Review. No abstract available.
• Immunosuppressive drugs in immune and inflammatory ocular disease.

  Hemady R, Tauber J, Foster CS. Hemady R, et al. Surv Ophthalmol. 1991 Mar-Apr;35(5):369-85. doi: 10.1016/0039-6257(91)90186-j. Surv Ophthalmol. 1991. PMID: 2038720 Review.